Insider · CIK 0001663041

Bukofzer Stan

Reports to the SEC for 2 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001663041

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-04-02	Assertio Therapeutics, IncF Tax Payment	SVP, Chf Scitfc & Tech Officer	FTax Payment	−7,433 sh	$0.65	−$4,806.921	62,916
2020-04-02	Assertio Therapeutics, IncRestricted Stock UnitsM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	−25.4K sh	—	—	40,584
2020-04-02	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	+25.4K sh	—	—	70,349
2020-04-02	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	+25.4K sh	—	—	70,349
2020-04-02	Assertio Therapeutics, IncF Tax Payment	SVP, Chf Scitfc & Tech Officer	FTax Payment	−7,433 sh	—	—	62,916
2020-04-02	Assertio Therapeutics, IncRestricted Stock UnitsM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	−25.4K sh	—	—	40,584
2020-02-12	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	+27.6K sh	—	—	54,524
2020-02-12	Assertio Therapeutics, IncF Tax Payment	SVP, Chf Scitfc & Tech Officer	FTax Payment	−9,545 sh	$1.35	−$12.9K	44,979
2020-02-12	Assertio Therapeutics, IncRestricted Stock UnitsM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	−27.6K sh	—	—	55,175
2020-02-04	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Chf Scitfc & Tech Officer	AAward	+327K sh	—	—	326,577
2019-08-13	Assertio Therapeutics, IncP Purchase	SVP, Chf Scitfc & Tech Officer	PPurchase	+4,000 sh	$1.56	+$6,228	26,936
2019-04-02	Assertio Therapeutics, IncRestricted Stock UnitsM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	−25.4K sh	—	—	65,954
2019-04-02	Assertio Therapeutics, IncM Exercise/Conversion	SVP, Chf Scitfc & Tech Officer	MExercise/Conversion	+25.4K sh	—	—	30,370
2019-04-02	Assertio Therapeutics, IncF Tax Payment	SVP, Chf Scitfc & Tech Officer	FTax Payment	−7,434 sh	$5.16	−$38.4K	22,936
2019-03-14	Assertio Therapeutics, IncP Purchase	SVP, Chf Scitfc & Tech Officer	PPurchase	+5,000 sh	$4.13	+$20.7K	5,000
2019-02-12	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Chf Scitfc & Tech Officer	AAward	+82.8K sh	—	—	82,763
2019-02-12	Assertio Therapeutics, IncPerformance SharesA Award	SVP, Chf Scitfc & Tech Officer	AAward	+18.6K sh	—	—	18,570
2018-04-02	Assertio Therapeutics, IncRestricted Stock UnitsA Award	SVP, Chf Scitfc & Tech Officer	AAward	+91.3K sh	—	—	91,324
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−300K sh	—	—	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−2,500 sh	$1.52	−$3,800	0
2017-12-11	Ocera Therapeutics, Inc.D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−200K sh	$1.52	−$304K	0
2017-12-11	Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−208K sh	—	—	0
2017-03-29	Ocera Therapeutics, Inc.A Award	Chief Medical Officer	AAward	+200K sh	—	—	202,500
2016-12-15	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+208K sh	—	—	208,350
2016-10-13	Ocera Therapeutics, Inc.P Purchase	Chief Medical Officer	PPurchase	+2,500 sh	$2.64	+$6,597.5	2,500
2016-01-05	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+300K sh	—	—	300,000
2016-01-05	Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+100K sh	—	—	100,000

Recent filings

Accepted (ET)
Apr 34/A
Bukofzer Stan0001005201-20-000027
SEC(opens sec.gov)
Apr 34
Bukofzer Stan0001005201-20-000025
SEC(opens sec.gov)
Feb 124
Bukofzer Stan0001005201-20-000011
SEC(opens sec.gov)
Feb 64
Bukofzer Stan0001005201-20-000005
SEC(opens sec.gov)
Aug 144
Bukofzer Stan0001005201-19-000099
SEC(opens sec.gov)
Apr 34
Bukofzer Stan0001005201-19-000058
SEC(opens sec.gov)
Mar 184
Bukofzer Stan0001005201-19-000045
SEC(opens sec.gov)
Feb 144
Bukofzer Stan0001005201-19-000019
SEC(opens sec.gov)
Apr 44
Bukofzer Stan0001179110-18-005443
SEC(opens sec.gov)
Dec 114
Bukofzer Stan0000899243-17-028422
SEC(opens sec.gov)

Companies

Address

C/O OCERA THERAPEUTICS, INC. 525 UNIVERSITY AVENUE, SUITE 610

PALO ALTO, CA, 94301